Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent consensus recommendations suggest starting hypoglycemia treatment with 5 to 10 g of simple carbohydrates for automated insulin delivery systems where insulin pump algorithms integrate real-time data from continuous glucose monitors [28].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There are separate consensus recommendations for people using automated insulin delivery who experience a hypoglycemia caused by exercise or excessive bolus of rapid-acting insulin [28].”
From Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus (2026) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“By 2023, six out of these proposed algorithms advanced to systems accepted in the clinical practice: Medtronic 670G/770G, Medtronic 780G, CamAPS FX developed in Cambridge, UK, the French system Diabeloop, Tandem's Control-IQ, and Insulet's Omnipod 5. 112”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationInternational consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citationState of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Self-citationUpdated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals
Flanagin, A., Frey, T., Christiansen, S. L., & AMA Manual of Style Committee (2021) · JAMA · doi:10.1001/jama.2021.13304 · Cited by 1,615
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Self-citationSafety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Self-citationGarg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citation
Research works printed but not linked: 1
- 28. Ware J, Allen JM, Boughton CK, et al. Randomized trial of closedloop control in very young children with type 1 diabetes. N Engl J Med. 2022; 386 (3):209-219.
Cited by
Items 301–400 of 443
Lehmann, V. F., Noti, F., Laimer, M. W., Stettler, C., & Züger, T. (2023) · Swiss Medical Weekly · doi:10.57187/s.3501 · Cited by 1
Insulin Delivery Hardware: Pumps and Pens
Lal, R., & Leelarathna, L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2503 · Cited by 1
Self-citationGlucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
Schlüter, S., Deiss, D., Gehr, B., Lange, K., von Sengbusch, S., Thomas, A., Ziegler, R., Wiesner, T., & Freckmann, G. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6668 · Cited by 2
Automatische Insulinabgabe-Systeme („AID-Systeme“)
Gehr, B., & Gölz, S. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2029-5259 · Cited by 2
“Eine internationale Expertengruppe hat in einer Konsensusempfehlung den generellen Umgang mit AID-Systemen sehr ausführlich veröffentlicht, die ge-nannte Publikation ist zur Vertiefung zu empfehlen [13].”
BackgroundUpdate on recent advances in technology in type 1 diabetes
Aslam, A., Thabit, H., & Leelarathna, L. (2024) · British Journal of Diabetes · doi:10.15277/bjd.2024.440 · Cited by 3
Self-citationTauschmann, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01240-7 · Cited by 1
Shahid, A., & Lewis, D. M. (2024) · Diabetology · doi:10.3390/diabetology5050038 · Cited by 1
“However, the delay in insulin's peak effect and the pharmacokinetic curve[3] present challenges in synchronizing dosage with variables such as food intake and physical activity[4], which can influence glucose-related fluctuations and result in hypoglycemia.”
BackgroundMesa, A., Roca, D., Granados, M., Pueyo, I., Cabré, C., Amor, A. J., Solà, C., Matas, O., Castanys, J., Conget, I., et al. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.11.004 · Cited by 1
Romero, P. E., Güemes, M., Guijo, B., Martos‐Moreno, G. Á., Román, J. P., & Argente, J. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.11.010 · Cited by 6
Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
Schlüter, S., Deiss, D., Gehr, B., Lange, K., von Sengbusch, S., Thomas, A., Ziegler, R., Wiesner, T., & Freckmann, G. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01275-w · Cited by 1
Gonçalves, J., Ferreira, H. U., Gamboa, C., Namora, G., Queirós, J. C., & Belo, S. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2025.0001 · Cited by 1
Franceschi, R., Mozzillo, E., Candia, F. D., Fanti, S., Maines, E., Guarnieri, C., Maffeis, C., Ros, A. D., Piccoli, E., Pertile, R., et al. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2025.0022 · Cited by 3
“These systems automatically adjust basal insulin infusion to the current glucose level together with autocorrection dosing, and they are more ef fi cient in improving glucose control 16,17 and psychological outcomes.”
Grudziąż-Sękowska, J., Sękowski, K. B., Grześczyk-Nojszewska, Z., Pinkas, J., Ostrowski, J., & Jankowski, M. (2025) · Health Problems of Civilization · doi:10.5114/hpc.2025.151047 · Cited by 1
Martín‐Payo, R., Fernandez-Alvarez, M. D. M., García-García, R., Pérez-Varela, Á., Surendran, S., & Galán, I. R. (2024) · Anales de Pediatría · doi:10.1016/j.anpedi.2024.05.018 · Cited by 1
New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems
Sala-Mira, I. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/192684 · Cited by 3
Shah, V. N., Aktürk, H. K., Trahan, A. C., Piquette, N., Wheatcroft, A., Schertz, E. M., CARMELO, K., Müeller, L., WHITE, K. N., Fu, L., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241229074 · Cited by 1
Self-citationArtificial Pancreas: The First 20 Years*
Doyle, F. J., & Kovatchev, B. P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0134 · Cited by 4
Self-citationPrince, N., Lochnan, H., Shorr, R., Garon-Mailer, A., & Sun, C. J. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02144-3
Diabetestechnologie bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1
Rami-Merhar, B. M. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00975-5
Automatisierte Insulindosierung: Ideale Diabeteskontrolle mit vielen offenen Fragen
Freckmann, G., Deiss, D., Ziegler, R., & Schlüter, S. (2023) · Deutsches Ärzteblatt · doi:10.3238/persdia.2023.03.24.01 · Cited by 1
Shah, V. N. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000820
Self-citationVerso il pancreas artificiale: i sistemi ibridi ad ansa chiusa
Molfetta, S. D., de Candia, S., Giorgino, F., & Laviola, L. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01318-2
Individualized intensive insulin therapy of diabetes: Not only the goal, but also the time
Hu, Y., Chen, H., & Ma, J. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i1.11
New Technologies for Glucose Monitoring
Danne, T., & Kordonouri, O. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch32
Self-citationHope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes
Thivolet, C. H. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101510
Ahmed, A., Taj, I., Anis, N.-E.-S., Farhan, K., Tariq, M. B., & Raufi, N. K. (2024) · International Journal of Surgery Global Health · doi:10.1097/gh9.0000000000000431
Traiter les hypoglycémies iatrogènes à l’ère des nouvelles technologies
Monnier, L., & Colette, C. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.02.002
Perfilando la tecnología en diabetes
Gómez, N. B., Jiménez-Salazar, S., Delgado, M. R., Botero, J. F., & Rincón, A. R. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.1.852
Guo, E. (2024) · Scalable Computing Practice and Experience · doi:10.12694/scpe.v25i3.2709
“The outcomes of this study can also be used to teach insulin pumps and improve closed-loop systems [18, 11, 20, 13].”
BackgroundDeveloping Strategies to Improve Diabetes Management in College-Going Young Adults
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4815-8
Automated Insulin Delivery in Women With Pregnancy Complicated by Type 1 Diabetes
Lee, T., Collett, C., Bergford, S., Hartnell, S., SCOTT, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K. D., Rankin, D., et al. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0001016664.40824.26
Self-citationIzquierdo, F. J. E., García, M. J. A., Vaquero, A. A. C., Gamero, J. A. L., Gómez-Turégano, P., Andrada, M. L., Pearson, A. C., & Figueredo, R. J. G. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.03.002
Meyer, L. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.04.007
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
Type 1 diabetes: Prevention and screening in focus
Milicic, T. J., Jotić, A., Lukić, L., Macesic, M. V., Gajović, J. S., Stoiljkovic, M. M., Milovancevic, M. M., Rafailović, Đ., Božović, A., Radisavljević, N., et al. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-49676
Owaydah, A., Abouglila, K., & Liloglou, T. (2024) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.1055/s-0044-1787111
Mesa, A., Roca, D., Granados, M., Pueyo, I., Cabré, C., Amor, A. J., Solà, C., Matas, O., Castanys, J., Conget, I., et al. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.05.012
Romero, P. E., Güemes, M., Guijo, B., Martos‐Moreno, G. Á., Román, J. P., & Argente, J. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.07.002
Lange, K., & Saßmann, H. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01233-6
Hamilton, B., Williams, L.-M., Gill, G., Liepert, M., Wilzer, J., Ladak, A., Oliviero, E., Garon-Mailer, A., & Sun, C. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.10.010
Reinforcement Learning Adjustment of Conventional Insulin Therapy for People with Type 1 Diabetes
Serafini, M. C., Fushimi, E., & Garelli, F. (2024) · IEEE Biennial Congress of Argentina (ARGENCON) · doi:10.1109/argencon62399.2024.10735891 · Cited by 2
“…in regards to TBR (which is crucial for patient safety), managing to reduce it to acceptable levels (less than 4 % according to the last consensus [20]) by the third week across all scenarios, while the scheme following the SoC guideline, given its more conservative nature, only reduces TBR after…”
BackgroundEffects of Physical and Psychological Stress Inducement and Combined Activities on Glycemia
Siket, M., Abdel-Latif, M. M., Rashid, M. M., Park, M., Bronas, U. G., Sharp, L. K., Quinn, L., & Çınar, A. (2024) · Wearable and Implantable Body Sensor Networks · doi:10.1109/bsn63547.2024.10780622 · Cited by 1
Les insulines « intelligentes » : une voie futuriste encore en quête de développement
Monnier, L., Colette, C., & Benhamou, P. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.05.005
Huerta‐Saenz, L. (2025) · Springer eBooks · doi:10.1007/978-3-031-85765-2_46
Insulinothérapie fonctionnelle
Zimmermann, C., Collette, A., & Borot, S. (2025) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(24)43373-8
Dimitropoulou, N. M., Eussen, S. J. P. M., Schalkwijk, C. G., & de Galan, B. E. (2025) · Diabetologia · doi:10.1007/s00125-025-06469-5
Active insulin time setting in MiniMed™ 780G: Impact on glucose control and patient perception
Izquierdo, F. J. E., García, M. J. A., Gómez-Turégano, P., Andrada, M. L., Vaquero, A. A. C., Gamero, J. A. L., Domínguez, S. G., & Reyes, I. Á. (2025) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2025.501635
Addressing Deskilling as Automated Insulin Delivery Advances: What Is the Backup Plan?
Russell, L., Cook, K. P., & MacLeod, J. (2025) · ADCES in Practice · doi:10.1177/2633559x251346709
Diabete di tipo 1: l’evoluzione della tecnologia al servizio del paziente
Tinti, D., & Nobili, C. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01650-9
Jurao, F. L. D. R., Fushimi, E., & Garelli, F. (2025) · Artificial Organs · doi:10.1111/aor.15064
Fifteen-minute consultation: Illness management in type 1 diabetes
Tucker, K. L., Stephenson, T., & Mathai, M. (2025) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2024-328407
System Failure in Type 1 Diabetes: What Stakeholders Need to Know to Expedite Therapeutic Options
Dayan, C. M., Mathieu, C., Lowenstein, D., & Soler, L. (2025) · Diabetes Spectrum · doi:10.2337/ds25-0024
Model based analytical approach for physical activity quantification in people with type 1 diabetes
Jurao, F. L. D. R., Fushimi, E., & Garelli, F. (2025) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-025-03467-y · Cited by 1
Rizvi, S. R., Desjardins, D., Kaur, R. J., Wood‐Wentz, C. M., Crusan, D. J., Reid, C. L., Trinidad, M. C., Bailey, K. R., & Kudva, Y. C. (2025) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2025.100664 · Cited by 1
Medications for the Management of Hypoglycemia
Giruzzi, M. E. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch28
Pharmacologic Therapy for Type 2 Diabetes
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch04
Pharmacologic Therapy for Type 1 Diabetes
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch01
Chambers, A., & Halperin, I. J. (2025) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2025.3345 · Cited by 1
Powell, C. (2025) · Journal of Human Development and Capabilities · doi:10.1080/19452829.2025.2587104 · Cited by 1
“The advent of HCLs has revolutionised healthcare and wellbeing for diabetics, with research suggesting that their usage significantly improves glucose control and quality of life (Phillip et al. 2023).”
Elbarbary, N. S., & Ismail, E. A. R. (2024) · Figshare · doi:10.6084/m9.figshare.24320090
Resmini, E., Zarra, E., Dotti, S., Rotondi, G., Cornaghi, A. V., Madaschi, S., Cimino, E., Massari, G., Pezzaioli, L. C., Buoso, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26749133
Elbarbary, N. S., & Ismail, E. A. R. (2023) · Figshare · doi:10.6084/m9.figshare.24319951
Resmini, E., Zarra, E., Dotti, S., Rotondi, G., Cornaghi, A. V., Madaschi, S., Cimino, E., Massari, G., Pezzaioli, L. C., Buoso, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26749127
Resmini, E., Zarra, E., Dotti, S., Rotondi, G., Cornaghi, A. V., Madaschi, S., Cimino, E., Massari, G., Pezzaioli, L. C., Buoso, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26749130
Insulin pumps and artificial pancreas
Markakis, K. P., & Vazeou, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00296-x
Delamater, A. M., Pulgarón, E. R., Guevara, G., Washington, S., Franz, D. Z., Gómez, R., Felipe, D. L., Bhat, J. N., & Chalew, S. A. (2025) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251397906
“48”
Croos, J., Shooshtarian, A. K., Stotesbury, B., Gallen, G., Ismail, K., Rosenthal, M. J., Cheah, Y. S., Calcia, M., Lovie, K., Ahuja, A., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70432
“47 Reduced cognition, which can occur in those with type 1 diabetes and comorbid depression, 48 has been reported by clinicians as a possible barrier to HCL use.”
Self-citationKm, C., Ting, W., Lee, Y.-J., Huang, C.-Y., Lin, C., Huang, S.-K., Lee, Y.-C., Wang, L.-T., Kao, Y.-E., Wu, Y.-H., et al. (2026) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2025.10.010
Courtney, A., Comerford, S., & Owens, L. A. (2026) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04245-3
“Randomized controlled trials and single-arm comparator studies of hybrid AID systems report mean improvements in TIR of 9–16% and reductions in HbA1c of approximately 0.3–0.5% [28].”
InfluentialAl-Taie, A., Hafida, M., Abdulsattar, M., & Mahmoud, R. E. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00597-z · Cited by 1
“The most technically advanced closed-loop systems are hybrid closed-loop therapy systems, reflects the combination of algorithm-directed insulin delivery, which necessitate user-initiated prandial insulin dosages [54, 68].”
Glycemic management in adults with type 1 diabetes
Koliaki, C. C., & Liatis, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00317-4
Batir, D. M., Boev, M., Gurău, G., Matei, M. N., Nechita, A., & Maftei, N.-M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014475
Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
Schlüter, S., Deiss, D., Gehr, B., Lange, K., von Sengbusch, S., Thomas, A., Ziegler, R., Wiesner, T., & Freckmann, G. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01450-1
Causal mediation pathways in continuous postprandial glucose monitoring for type 1 diabetes patients
Hilligoss, S., & Qu, A. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00127-z
Wu, Z., Lebbar, M., Lal, R., Bonhoure, A., Messier, V., Nguyen, É., Boudreau, V., Brazeau, A., & RABASA-LHORET, R. P. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70705 · Cited by 1
Self-citationConsensus on Applications and Emerging Needs for Continuous Glucose Monitoring in Portugal
Neves, J. S., Teixeira, S., Neves, Â. S., Sampaio, L., Reis, M., Paiva, S., Mirante, A., Freitas, P., Nortadas, R., Melo, M., et al. (2026) · Endocrinology Insights · doi:10.1159/000551692
“It is expected that in the future, devices will communicate with each other in real time and that devices from different manufacturers will be inter-changeable [17, 41].”
González-Maroto, I., Moreno-Fernández, J., Beato-Víbora, P. I., & Quirós, C. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101757
Automated insulin delivery use in children and adolescents with type 1 diabetes across the world
Seget, S., Rusak, E., Pélicand, J., Fry, M., SHEANON, N. M., Schierloh, U. H. E., Xatzipsalti, M., Malinici, E. A., Tinti, D., Neylon, O. M., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113253 · Cited by 1
Editorial: Technologies for diabetes, volume III
Cardona‐Hernandez, R., Tinti, D., & Delvecchio, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1846249 · Cited by 1
“The most transformative technological development in diabetes care has been the emergence of AID systems, commonly referred to as hybrid closed-loop (HCL) or advanced hybrid closed-loop (AHCL) systems (4).”
Nagar, P., Rashid, M., Arora, S., Alam, S., Agrawal, M., & Basist, P. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01651-w
A comment from the AGDT on smart insulin pen therapy systems
Schlüter, S., Freckmann, G., & Lange, K. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01437-y
Al‐Bataineh, O. M., Abdallat, R., & Alfraihat, A. (2026) · Biomedicines · doi:10.3390/biomedicines14040900
Succurro, E., Cersosimo, G., Sarnelli, P., Brisinda, F. M., Gattuso, I., Mazza, V., Fabiano, G., Iorio, F., Arena, R., Mazzitello, G., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02690-9
Luo, Y., Jin, Z., Zhao, Y., Luo, Y., Xie, C., Sun, Y., Horowitz, M., Jones, K. L., Rayner, C. K., Ma, J., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70811
Mameli, C., Sodero, R., Gaudenzi, F., Redaelli, F. C., Hajro, A., Petitti, A., Lauriola, F., Panero, B., Ippoliti, A., Chiarelli, F., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04646-z
L’insulinothérapie automatisée : du concept à la pratique clinique, une évolution ininterrompue
Renard, É. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.02.013
Eiswirth, M. E., Resl, M., Kulzer, B., Roos, T., Trümpy, C., Balmer, M. L., Witthauer, L., Mader, J. K., Diem, P., Heinemann, L., et al. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261444041
Self-citationEhrmann, D., Roos, T., Kröger, J., Mühlen, H., Keuthage, W., Lueg, A., Scheper, N., Heinemann, L., Brandt, D., Hermanns, N., et al. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261442286
Self-citationSun, Z., Yang, S. M., Gao, L., Dou, L., & Zeng, B. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02194-0
“The long-term effectiveness of AID systems in real-world clinical practice remain insufficiently investigated [15].”
Type 1 Diabetes Management Beyond Insulin: Aligning Evidence, Research, and Regulation
Ackeifi, C. A., & Shah, V. N. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.04.016
Self-citationGestion des systèmes de délivrance automatisée d’insuline en situation d’activité physique
Joubert, M. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.05.002
Quezada, D. Z. A., Porras, P. C. V., Aranda, A. O. N., Gomez, H., Morán, R. C. D., Salas, V. L. A., Ortiz, Z. L., Rojas, L. M. H., Livia, D. P. R., Llaja, L. C., et al. (2026) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk11020231
“The attenuation of modality-related risk in automated insulin delivery users is also plausible in light of emerging data showing that AID systems can reduce, but not abolish, exercise-related glycemic instability [10,18,23,24].”
First Use of Control-IQ+ Technology in Newly Indicated Populations
Assadi, K. Z., D’Souza, E. W., Pinsker, J. E., & Messer, L. H. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261456818
Self-citationBrain-Hype and For-Profit Medical Devices
Vassallo, M., & Picozzi, M. (2026) · Journal of Bioethical Inquiry · doi:10.1007/s11673-025-10466-z
Diabetes Technology: Continuous Glucose Monitoring and Insulin Delivery
MacLeod, J., Willis, H. J., Sulik, B., & Chomko, M. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch08 · Cited by 1
Athanasopoulou, M., Tsanti, M., Papasotiriou, M., Efthymiadou, A., Giannakopoulos, A., Chrysis, D., & Kostopoulou, E. (2026) · Children · doi:10.3390/children13060819 · Cited by 1
“In recent years, a major shift in diabetes technology has occurred with the emergence of automated insulin delivery (AID) systems, also referred to as hybrid closed-loop systems or “artificial pancreas” [18,22].”
InfluentialFacteurs de déséquilibre du diabète de type 1
Joubert, M. (2026) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(26)44170-8
SUSUL, K., Matejko, B., Surowiec, P., Malecki, M., Klupa, T., & CYRANKA, K. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1870978
Un nouveau venu : le Réseau d’Investigation de l’Insulinothérapie Automatisée (R2IA)
Riveline, J., Zakaria, A., Joubert, M., Fagherazzi, G., Detournay, B., & Renard, É. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.06.006
Metadata
- Authors
- Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., Amiel, S. A., Bally, L., Beck, R. W., Biester, S., Biester, T., Blanchette, J. E., Bosi, E., Boughton, C. K., Breton, M. D., Brown, S. A., Buckingham, B. A., Cai, A., Carlson, A. L., Castle, J. R., Choudhary, P., Close, K. L., Cobelli, C., Criego, A. B., Davis, E., de Beaufort, C., de Bock, M. I., DeSalvo, D. J., DeVries, J. H., Dovc, K., Doyle, F. J., Ekhlaspour, L., Shvalb, N. F., Forlenza, G. P., Gallen, G., Garg, S. K., Gershenoff, D. C., Gonder-Frederick, L. A., Haidar, A., Hartnell, S., Heinemann, L., Heller, S., Hirsch, I. B., Hood, K. K., Isaacs, D., Klonoff, D. C., Kordonouri, O., Kowalski, A., Laffel, L., Lawton, J., Lal, R. A., Leelarathna, L., Maahs, D. M., Murphy, H. R., Nørgaard, K., O’Neal, D., Oser, S., Oser, T., Renard, E., Riddell, M. C., Rodbard, D., Russell, S. J., Schatz, D. A., Shah, V. N., Sherr, J. L., Simonson, G. D., Wadwa, R. P., Ward, C., Weinzimer, S. A., Wilmot, E. G., & Battelino, T.
- Affiliations
- Tel Aviv University (IL)
- HealthPartners (US)
- Southern Health NHS Foundation Trust (GB)
- Kinderkrankenhaus auf der Bult (DE)
- University of Cambridge (GB)
- University of Virginia (US)
- University of Colorado Anschutz (US)
- CGParkin Communications, Inc. , Henderson, NV , USA
- Joslin Diabetes Center (US)
- King's College London (GB)
- University of Bern (CH)
- Jaeb Center for Health Research (US)
- University of Utah (US)
- Vita-Salute San Raffaele University (IT)
- Stanford Medicine (US)
- Close Concerns (United States) (US)
- Oregon Health & Science University (US)
- University of Leicester (GB)
- University of Padua (IT)
- The Kids Research Institute Australia (AU)
- Diabetes & Endocrine Care Clinique Pédiatrique DECCP/Centre Hospitalier Luxembourg, and Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch sur Alzette, GD Luxembourg/Department of Paediatrics, UZ-VUB , Brussels , Belgium
- Department of Paediatrics, University of Otago , Christchurch , New Zealand
- Baylor College of Medicine (US)
- Amsterdam University Medical Centers (NL)
- Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children’s Hospital, Ljubljana, Slovenia, and Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia
- Harvard University (US)
- Lucile Packard Children's Hospital (US)
- The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel , 49202 Petah Tikva , Israel
- McGill University (CA)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Science Consulting in Diabetes GmbH , Kaarst , Germany
- University of Sheffield (GB)
- University of Washington (US)
- Cleveland Clinic (US)
- Diabetes Research Institute, Mills-Peninsula Medical Center , San Mateo, CA 94010 , USA
- Breakthrough T1D (US)
- University of Edinburgh (GB)
- University of Manchester (GB)
- University of East Anglia (GB)
- University of Copenhagen (DK)
- Department of Medicine and Department of Endocrinology, St Vincent’s Hospital Melbourne, University of Melbourne , Melbourne , Australia
- Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, and Institute of Functional Genomics, University of Montpellier, CNRS, INSERM , Montpellier , France
- York University (CA)
- Biomedical Informatics Consultants LLC , Potomac, MD , USA
- University of Florida (US)
- Yale University (US)
- University of Nottingham (GB)
- University of Ljubljana (SI)
- Corresponding author
- Phillip, Moshe
- Nimri, Revital
- ORCID
- Phillip, Moshe
- Nimri, Revital
- Bergenstal, Richard M
- Barnard-Kelly, Katharine
- Danne, Thomas
- Hovorka, Roman
- Kovatchev, Boris P
- Messer, Laurel H
- Parkin, Christopher G
- Amiel, Stephanie A
- Bally, Lia
- Beck, Roy W
- Biester, Torben
- Blanchette, Julia E
- Bosi, Emanuele
- Boughton, Charlotte K
- Breton, Marc D
- Brown, Sue A
- Buckingham, Bruce A
- Carlson, Anders L
- Castle, Jessica R
- Choudhary, Pratik
- Close, Kelly L
- Cobelli, Claudio
- Criego, Amy B
- Davis, Elizabeth
- de Beaufort, Carine
- de Bock, Martin I
- DeSalvo, Daniel J
- DeVries, J Hans
- Dovc, Klemen
- Doyle, Francis J
- Ekhlaspour, Laya
- Shvalb, Naama Fisch
- Forlenza, Gregory P
- Gallen, Geraldine
- Garg, Satish K
- Gonder-Frederick, Linda A
- Haidar, Ahmad
- Hartnell, Sara
- Heinemann, Lutz
- Heller, Simon
- Hirsch, Irl B
- Hood, Korey K
- Isaacs, Diana
- Klonoff, David C
- Kordonouri, Olga
- Kowalski, Aaron
- Laffel, Lori
- Lawton, Julia
- Lal, Rayhan A
- Leelarathna, Lalantha
- Maahs, David M
- Murphy, Helen R
- Nørgaard, Kirsten
- Oser, Sean
- Oser, Tamara
- Renard, Eric
- Riddell, Michael C
- Rodbard, David
- Russell, Steven J
- Schatz, Desmond A
- Shah, Viral N
- Sherr, Jennifer L
- Simonson, Gregg D
- Wadwa, R Paul
- Weinzimer, Stuart A
- Wilmot, Emma G
- Battelino, Tadej
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2022-09-06
- Volume
- 44
- Issue
- 2
- Pages
- 254-280
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC9985411
- OpenAlex
- W4294783598
- Semantic Scholar
- 28646f57b5b3cbcfac8f10ea51308aadbf9e4f00
- Cited by
- 443
- References
- 144
- Citations by year
- 2026: 102 · 2025: 121 · 2024: 141 · 2023: 76 · 2022: 3
- FWCI
- 63.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- HAL (submittedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc-nd)
- Figshare (submittedVersion, cc-by-nc-nd)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Open Access CRIS of the University of Bern
- Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Leona M. and Harry B. Helmsley Charitable Trust
- University of Virginia
- Bigfoot Biomedical
- Insulet Corporation
- MannKind Corporation
- Dexcom
- Steno Diabetes Center Copenhagen (SDCC 3.E Technology)
- Cardinal Health
- Tandem Diabetes Care
- National Institute for Health and Care Research (16/35/01, CL-2020-14-801)
- Novo Nordisk
- Roche Diabetes Care
- National Institutes of Health (UL1TR001863)
- University of Colorado Denver
- Abbott Diabetes Care
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK121942, K23DK122017, R01DK129553, P30DK045735)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- artificial pancreas, diabetes management, glycemic control, hypoglycemia risk, insulin pump therapy, continuous glucose monitoring, eligibility criteria, clinical guidelines
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Blood Glucose Self-Monitoring, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.